EASL recommends extending the Recommendation to liver cancer for high-risk groups living with chronic liver diseases; these patients are identifiable, have a high risk of liver cancer, and can be offered curative treatment if their liver cancer is diagnosed early. Furthermore, liver cancer detection tools are easily available and affordable.